Advanced Search

    Technical Analysis for OKYO - Okyo Pharma Corporation

    Grade Last Price % Change Price Change
    F 2.14 15.68% 0.29
    OKYO closed down 17.78 percent on Thursday, March 23, 2023, on 69 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical OKYO trend table...
    Date Alert Name Type % Chg
    180 Bearish Setup Bearish Swing Setup 15.68%
    Slingshot Bearish Bearish Swing Setup 15.68%
    1,2,3 Pullback Bullish Bullish Swing Setup 15.68%
    Lower Bollinger Band Walk Weakness 15.68%
    Outside Day Range Expansion 15.68%
    Wide Bands Range Expansion 15.68%
    Below Lower BB Weakness 15.68%
    Lower Bollinger Band Touch Weakness 15.68%
    Oversold Stochastic Weakness 15.68%
    Lizard Bullish Bullish Day Trade Setup -4.89%
    Older End-of-Day Signals for OKYO ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    Possible Inside Day about 3 hours ago
    Possible NR7 about 3 hours ago
    Up 10% about 7 hours ago
    Up 5% about 7 hours ago
    Up 3% about 7 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators Basic chart:

    Profile

    OKYO Pharma Limited operates as a life sciences and biotechnology company in the United Kingdom. Its development program includes Chemerin for the treatment of ocular inflammation, dry eye disease, and ocular neuropathic pain; and BAM-8, a non-opiod analgesic. OKYO Pharma Limited is headquartered in London, the United Kingdom.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pain Biotechnology Science Life Sciences Disease Drugs Psychoactive Drugs Inflammation Analgesic Neuropathic Pain

    Is OKYO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 3 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 16 OKYO Pharma Announces Phase 2 Trial of OK-101 Drug to Treat Dry Eye Disease is now listed on the ClinicalTrials.gov Public Website
    Mar 14 OKYO Pharma Limited announces U.S.$5.74 million Global Private Placement and investment by directors and members of senior management
    Mar 13 OKYO Pharma Limited Prices $5.3 Million Offering of ADSs
    Mar 10 SmallCapsDaily Interviews OKYO Pharma CEO Dr. Gary Jacob, PHD
    Feb 28 OKYO Pharma Announces Custom Clearance of GMP Packaged OK-101 Drug to be Used in Phase 2 Clinical Trial for Treating Dry Eye Disease
    Dec 21 OKYO to Participate at Biotech Showcase
    Nov 21 OKYO Pharma Announces U.S. IND Filing on OK-101 for the Treatment of Dry Eye Disease
    Oct 20 OKYO Pharma Ltd. Announces Participation in The ThinkEquity Conference
    See more OKYO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 8.0
    52 Week Low 1.6
    Average Volume 432,196
    200-Day Moving Average 2.96
    50-Day Moving Average 2.97
    20-Day Moving Average 2.74
    10-Day Moving Average 2.50
    Average True Range 0.61
    RSI 33.33
    ADX 31.98
    +DI 21.77
    -DI 14.18
    Chandelier Exit (Long, 3 ATRs) 2.58
    Chandelier Exit (Short, 3 ATRs) 3.67
    Upper Bollinger Bands 3.57
    Lower Bollinger Band 1.92
    Percent B (%b) -0.04
    BandWidth 60.22
    MACD Line -0.26
    MACD Signal Line -0.16
    MACD Histogram -0.1002
    Fundamentals Value
    Market Cap 12.44 Million
    Num Shares 673 Million
    EPS -0.70
    Price-to-Earnings (P/E) Ratio -2.64
    Price-to-Sales 0.00
    Price-to-Book 60.34
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.77
    Resistance 3 (R3) 2.87 2.66 2.61
    Resistance 2 (R2) 2.66 2.43 2.61 2.56
    Resistance 1 (R1) 2.26 2.29 2.16 2.16 2.51
    Pivot Point 2.05 2.05 2.00 2.00 2.05
    Support 1 (S1) 1.65 1.82 1.55 1.55 1.19
    Support 2 (S2) 1.44 1.68 1.39 1.14
    Support 3 (S3) 1.04 1.44 1.09
    Support 4 (S4) 0.94